Stability of Split Tablets
The current pharmacy practice of splitting tablets has grown exponentially in the last few years to contain the ever growing cost of health care. At present, there is no scientific evidence in the public domain to demonstrate that the random splitting of tablets would not pose any safety concerns by compromising the quality of the product. The presentation would addresses the quality risk associated with the tablet splitting and the need for generating adequate scientific data before recommending a tablet splitting.
KeywordsCholesterol HPLC Statin Triglyceride Simvastatin
- Teng J, Song CK, Williams RL, Polli JE (2002) Lack of medication dose uniformity in commonly split tablets. JAMA 42:195–199Google Scholar